{
    "organizations": [],
    "uuid": "dbe8e56219de4c188cd25c75aedf1e302b72ea62",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-seikagaku-initiates-a-phase-iii-cl/brief-seikagaku-initiates-a-phase-iii-clinical-trial-in-the-u-s-for-si-6603-idUSL4N1Q90C2",
    "ord_in_thread": 0,
    "title": "BRIEF-Seikagaku initiates a phase III clinical trial (additional study) in the U.S. for SI-6603",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 19 (Reuters) - Seikagaku Corp\n* Says it will initiate a Phase III clinical trial (additional study) in the U.S. for SI-6603, indicated for the treatment of radicular leg pain (i.e. sciatica) due to a lumbar disc herniation.\nSource text in Japanese: goo.gl/1yFkhk\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-19T09:35:00.000+02:00",
    "crawled": "2018-02-19T16:52:52.039+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "seikagaku",
        "corp",
        "say",
        "initiate",
        "phase",
        "iii",
        "clinical",
        "trial",
        "additional",
        "study",
        "indicated",
        "treatment",
        "radicular",
        "leg",
        "pain",
        "sciatica",
        "due",
        "lumbar",
        "disc",
        "herniation",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}